Posters displayed

1. COMPARATIVE ANALYSIS OF MSCS OBTAINED FROM DIFFERENT FETAL ADNEXA TISSUES
2. QUALITY CONTROL AND SAFETY OF THE PROCUREMENT, PROCESSING, STORAGE, AND ADMINISTRATION OF MSCS FOR CELLULAR THERAPY
3. ALLOGENEIC MESENCHYMAL STROMAL CELLS (MSCs) CONTRIBUTE TO WOUND HEALING AND MODULATE T CELLS SUBSETS IN BURN MODEL
4. PLURIPOTENCY AND DIFFERENTIATION CONTROLING MICRORNAS SCREENING AND TARGET CHARACTERIZATION
5. THE EFFECT OF TREATMENT WITH DIPEPTIDYL PEPTIDASE-4 INHIBITOR ONAN ANIMAL MODEL OF TYPE 1 DIABETES
6. MECHANISMS OF T-CELL SUPPRESSION BY MESENCHYMAL STROMAL CELLS
7. GENERATION OF REPORTER CELL LINES TO THESTUDY OF PLURIPOTENCY MODULATION
8. _NP73/TAP73 EXPRESSION RATIO IS ASSOCIATED WITH POOR OUTCOME INACUTE PROMYELOCYTIC LEUKEMIA
9. IMMUNOLOGICAL MONITORING OF TYPE 1 DIABETES MELLITUS PATIENTS AFTER MESENCHYMAL STROMAL CELLS (MSCS) THERAPY
10. MOLECULAR MANIPULATION OF INHIBITORY PATHWAYS FOR IPS INDUCTION INCREASE
11. EVALUATION OF THE POTENTIAL ABILITY OF MULTIPOTENT MESENCHYMAL STROMAL CELLS OF AMNIOTIC FLUID TO DIFFERENTIATE IN LUNG CELLS LINEAGE – PARTIAL RESULTS
12. BRCA1 MUTATION SCREENING IN BRAZILIAN HEREDITARY BREAST CANCER AND OVARY SYNDROME USING HIGH RESOLUTION MELTING
13. NEW INSIGHTS INTO ENDOTHELIAL-TO-MESENCHYMAL TRANSITION
14. SYNTHETIC BIOLOGY AS A THERAPEUTIC APPROACH TO HAEMOPHILIA A
15. MULTIPOTENT MESENCHYMAL STROMAL CELLS WITHIN TUMOR STROMA PROMOTE MELANOMA METASTASIS
16. IN VITRO GENERATION OF MYELOID HEMATOPOIETIC CELLS FROM HUMAN EMBRYONIC STEM CELLS
17. GENE EXPRESSION ANALYSIS OF T CELLS SUBSETS FROM MS PATIENTS UNDERGOING AHSC TRANSPLANT REVEALS SIGNIFICANT CHANGES IN IMMUNE FUNCTION
18. CONTRIBUTION OF BONE MARROW-DERIVED CELLS IN THE TUMOR ANGIOGENESIS AND STROMA FORMATION IN A GFP CHIMERIC BONE MARROW MURINE MODEL
19. PRODUCTION OF HEMATOPOIETIC STEM/PROGENITOR CELLS FROM HUMAN EMBRYONIC STEM CELLS
20. RECONSTITUTION OF NAÏVE AND REGULATORY T CELL POPULATIONS IN TYPE 1 DIABETES AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
21. MESENCHYMAL STROMAL CELLS ISOLATED FROM MULTIPLE SCLEROSIS PATIENTS REVEALS IMMUNOSUPPRESSIVE AND IMMUNOREGULATORY PROPERTIES
22. STUDY OF MUTATIONS IN GENES METABOLIZERS OF CISPLATIN IN HEAD AND NECK CANCER
23. MICRORNA EXPRESSION PROFILE OF CD34+ CELLS IN A COCULTURE OP9-DL1 SYSTEM
24. TREGS GENERATED BY MESENCHYMAL STROMAL CELLS VERSUS TREGS INDUCED BY TGF-BETA, IL-2 AND ATRA: DIFFERENCES IN GENE EXPRESSION OF IMMUNOREGULATORY-RELATED MOLECULES
25. EARLY EVENTS OF ANTI-NEOPLASIC ACTIVITY OF AN ALKYLPHOSPHOLIPID ON ACUTE PROMYELOCYTIC LEUKEMIA CELLS REVEALED BY PROTEOMICS
26. POTENTIAL ROLE OF TCL1A IN THE PLURIPOTENT REPROGRAMMING OF FIBROBLASTS
27. DIAGNOSIC PLATFORMS FOR DETECTION OF LATENT AND PERSISTENT VIRUSES (PARVOVIRUS B19 AND CYTOMEGALOVIRUS) IN HEMATOPOIETIC STEM CELLS PREPARED FOR TRANSPLANTATION AND TRANSPLANT RECIPIENTS
28. EFFECTS OF 5-AZACYTIDINE ON THE EXPRESSION OF ALPHA-CARDIAC ACTIN DURING TRIGGERING OF PARTIAL CARDIOMYOGENIC DIFFERENTIATION IN PERICYTES FROM HUMAN ADIPOSE TISSUE
29. HTLV-1 STUDY IN HEMOTHERAPY CENTER OF RIBEIRÃO PRETO
30. DEVELOPMENT OF A PLATFORM FOR MOLECULAR DETECTION OF MYCOPLASMA IN CELL CULTURES
31. EXPRESSION OF MAJOR GENE REARRANGEMENT IS FOUND IN PATIENTS WITHPROSTATE CANCER HCFMRP